Nk Arora
- All
- News
- Videos
- Web Stories
-
"No Rise In Hospitalisation, Deaths": Covid Panel Chief On Surge In Cases
Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.
-
"No New Wave, Don't Need To Worry": Centre's Covid Panel Chief To NDTV
Pointing out that there has been no increase in hospital admissions and the death count due to Covid, he said the new mutation of the virus is more contagious but isn't causing serious disease.
-
Not One, 4 Virus Variants Causing China Surge: Centre's Covid Panel Chief
NK Arora, the chief on the Centre's Covid panel, told NDTV today that there is no need for panic over the fresh outbreak in China that has rung alarm bells across the world.
-
"Hybrid, Not Herd Immunity, Keeps India Safe": Covid Panel Chief Dr NK Arora To NDTV
India's fight against COVID-19 is shaping up much better than neighbouring China due to robust "hybrid immunity", the head of the country's vaccine task force told NDTV today in an exclusive interview.
-
India Should Keep Close Vigil On China's COVID-19 Rise: Covid Panel Chief
Amid the rising COVID cases in China, a top Indian health expert on Tuesday cautioned the people while asking them to keep a close vigil on the situation in the country.
-
Vaccine Against Cervical Cancer To Be In Immunisation Programme By Mid-2023
India would be in a position to roll out the indigenously developed Human Papillomavirus Vaccine (HPV) against cervical cancer for girls in the age group of 9-14 under the National Immunisation Programme by mid-2023, NTAGI chairperson Dr NK Arora sai
-
Monkeypox Not As Contagious As COVID-19, Says Covid Panel Chief
Monkeypox outbreak has been witnessed in nearly 20 countries, however, no suspected cases of the disease have been detected in India so far, referring to which, a health expert on Wednesday said that it is not as contagious as COVID-19.
-
WHO Estimate Of India Deaths "Preposterous, Untenable": Covid Panel Chief
WHO also said they chose the mathematical model as many countries "still lack capacity for reliable mortality surveillance and therefore do not collect and generate the data needed to calculate excess mortality".
-
Variants Will Keep On Coming, Nothing To Panic About: Covid Panel Head
New COVID-19 variants will keep coming, however, the new variants aren't causing severe diseases or increasing the number of cases said Chairman of the COVID-19 working group of India said.
-
Vaccination For 12-14-Year-Olds Likely From March, Says Covid Panel Chief
India will likely begin inoculating children in the 12-14 age groups against Covid from March as the 15-18 population will mostly be fully vaccinated by then, Dr NK Arora, Chairman of the COVID-19 working group NTAGI, said today.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Covaxin Shelf-Life Extension Not A Problem: Covid Task Force Chief
It is absolutely safe, underlined the head of the India's vaccine task force chief on the vexing question of extending the shelf life of Covid vaccine, Covaxin, being given to teenagers (15-18) under the national Covid immunisation programme.
-
Decision On Which Vaccines Will Be Given As Boosters Within 2 Days
A decision on which vaccines will be given as boosters will be taken within two days, Dr NK Arora, chairman of the country's Covid Task Force, told NDTV today.
-
Third Wave On, 75% Cases In Metros Are Omicron: Covid Task Force Boss
A large chunk of Omicron cases in India as the country faces a third wave of the COVID-19 pandemic have been reported from big cities, the head of the country's vaccine task force Dr NK Arora told NDTV today, adding the third wave is here.
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
"No Rise In Hospitalisation, Deaths": Covid Panel Chief On Surge In Cases
Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.
-
"No New Wave, Don't Need To Worry": Centre's Covid Panel Chief To NDTV
Pointing out that there has been no increase in hospital admissions and the death count due to Covid, he said the new mutation of the virus is more contagious but isn't causing serious disease.
-
Not One, 4 Virus Variants Causing China Surge: Centre's Covid Panel Chief
NK Arora, the chief on the Centre's Covid panel, told NDTV today that there is no need for panic over the fresh outbreak in China that has rung alarm bells across the world.
-
"Hybrid, Not Herd Immunity, Keeps India Safe": Covid Panel Chief Dr NK Arora To NDTV
India's fight against COVID-19 is shaping up much better than neighbouring China due to robust "hybrid immunity", the head of the country's vaccine task force told NDTV today in an exclusive interview.
-
India Should Keep Close Vigil On China's COVID-19 Rise: Covid Panel Chief
Amid the rising COVID cases in China, a top Indian health expert on Tuesday cautioned the people while asking them to keep a close vigil on the situation in the country.
-
Vaccine Against Cervical Cancer To Be In Immunisation Programme By Mid-2023
India would be in a position to roll out the indigenously developed Human Papillomavirus Vaccine (HPV) against cervical cancer for girls in the age group of 9-14 under the National Immunisation Programme by mid-2023, NTAGI chairperson Dr NK Arora sai
-
Monkeypox Not As Contagious As COVID-19, Says Covid Panel Chief
Monkeypox outbreak has been witnessed in nearly 20 countries, however, no suspected cases of the disease have been detected in India so far, referring to which, a health expert on Wednesday said that it is not as contagious as COVID-19.
-
WHO Estimate Of India Deaths "Preposterous, Untenable": Covid Panel Chief
WHO also said they chose the mathematical model as many countries "still lack capacity for reliable mortality surveillance and therefore do not collect and generate the data needed to calculate excess mortality".
-
Variants Will Keep On Coming, Nothing To Panic About: Covid Panel Head
New COVID-19 variants will keep coming, however, the new variants aren't causing severe diseases or increasing the number of cases said Chairman of the COVID-19 working group of India said.
-
Vaccination For 12-14-Year-Olds Likely From March, Says Covid Panel Chief
India will likely begin inoculating children in the 12-14 age groups against Covid from March as the 15-18 population will mostly be fully vaccinated by then, Dr NK Arora, Chairman of the COVID-19 working group NTAGI, said today.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Covaxin Shelf-Life Extension Not A Problem: Covid Task Force Chief
It is absolutely safe, underlined the head of the India's vaccine task force chief on the vexing question of extending the shelf life of Covid vaccine, Covaxin, being given to teenagers (15-18) under the national Covid immunisation programme.
-
Decision On Which Vaccines Will Be Given As Boosters Within 2 Days
A decision on which vaccines will be given as boosters will be taken within two days, Dr NK Arora, chairman of the country's Covid Task Force, told NDTV today.
-
Third Wave On, 75% Cases In Metros Are Omicron: Covid Task Force Boss
A large chunk of Omicron cases in India as the country faces a third wave of the COVID-19 pandemic have been reported from big cities, the head of the country's vaccine task force Dr NK Arora told NDTV today, adding the third wave is here.
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
